Therapeutics
Search By Attributes
Search Results
| Name | Synonyms | FDA Status | Company | Target Type | Therapy Type | Approved For |
|---|---|---|---|---|---|---|
| LX1001 | AAVrh.10-APOE2, AAVrh.10hAPOE2 |
Alzheimer's Disease (Phase 1/2) | Lexeo Therapeutics | Amyloid-Related | DNA/RNA-based | |
| RG6289 | Alzheimer's Disease (Phase 1/2) | Hoffmann-La Roche | Amyloid-Related | Small Molecule | ||
| Trontinemab | RO7126209, RG6102 , Brain shuttle gantenerumab |
Alzheimer's Disease (Phase 1/2) | Hoffmann-La Roche | Amyloid-Related | Immunotherapy (passive) |